These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 21378259)
1. Injection drug users' access to a supervised injection facility in Vancouver, Canada: the influence of operating policies and local drug culture. Small W; Shoveller J; Moore D; Tyndall M; Wood E; Kerr T Qual Health Res; 2011 Jun; 21(6):743-56. PubMed ID: 21378259 [TBL] [Abstract][Full Text] [Related]
2. Injection drug users' perceptions regarding use of a medically supervised safer injecting facility. Petrar S; Kerr T; Tyndall MW; Zhang R; Montaner JS; Wood E Addict Behav; 2007 May; 32(5):1088-93. PubMed ID: 16930849 [TBL] [Abstract][Full Text] [Related]
3. Seeking refuge from violence in street-based drug scenes: women's experiences in North America's first supervised injection facility. Fairbairn N; Small W; Shannon K; Wood E; Kerr T Soc Sci Med; 2008 Sep; 67(5):817-23. PubMed ID: 18562065 [TBL] [Abstract][Full Text] [Related]
4. Attendance, drug use patterns, and referrals made from North America's first supervised injection facility. Tyndall MW; Kerr T; Zhang R; King E; Montaner JG; Wood E Drug Alcohol Depend; 2006 Jul; 83(3):193-8. PubMed ID: 16356659 [TBL] [Abstract][Full Text] [Related]
5. A micro-environmental intervention to reduce the harms associated with drug-related overdose: evidence from the evaluation of Vancouver's safer injection facility. Kerr T; Small W; Moore D; Wood E Int J Drug Policy; 2007 Jan; 18(1):37-45. PubMed ID: 17689342 [TBL] [Abstract][Full Text] [Related]
6. Changes in injecting practices associated with the use of a medically supervised safer injection facility. Stoltz JA; Wood E; Small W; Li K; Tyndall M; Montaner J; Kerr T J Public Health (Oxf); 2007 Mar; 29(1):35-9. PubMed ID: 17229788 [TBL] [Abstract][Full Text] [Related]
7. Nurse-delivered safer injection education among a cohort of injection drug users: evidence from the evaluation of Vancouver's supervised injection facility. Wood RA; Wood E; Lai C; Tyndall MW; Montaner JS; Kerr T Int J Drug Policy; 2008 Jun; 19(3):183-8. PubMed ID: 18367389 [TBL] [Abstract][Full Text] [Related]
8. "People knew they could come here to get help": an ethnographic study of assisted injection practices at a peer-run 'unsanctioned' supervised drug consumption room in a Canadian setting. McNeil R; Small W; Lampkin H; Shannon K; Kerr T AIDS Behav; 2014 Mar; 18(3):473-85. PubMed ID: 23797831 [TBL] [Abstract][Full Text] [Related]
9. Access to health and social services for IDU: the impact of a medically supervised injection facility. Small W; Van Borek N; Fairbairn N; Wood E; Kerr T Drug Alcohol Rev; 2009 Jul; 28(4):341-6. PubMed ID: 19594786 [TBL] [Abstract][Full Text] [Related]
10. Condom use among injection drug users accessing a supervised injecting facility. Marshall BD; Wood E; Zhang R; Tyndall MW; Montaner JS; Kerr T Sex Transm Infect; 2009 Apr; 85(2):121-6. PubMed ID: 18812391 [TBL] [Abstract][Full Text] [Related]
11. Do supervised injecting facilities attract higher-risk injection drug users? Wood E; Tyndall MW; Li K; Lloyd-Smith E; Small W; Montaner JS; Kerr T Am J Prev Med; 2005 Aug; 29(2):126-30. PubMed ID: 16005809 [TBL] [Abstract][Full Text] [Related]
12. Street-level policing in the Downtown Eastside of Vancouver, Canada, during the 2010 Winter Olympics. Small W; Krusi A; Wood E; Montaner J; Kerr T Int J Drug Policy; 2012 Mar; 23(2):128-33. PubMed ID: 21885271 [TBL] [Abstract][Full Text] [Related]
13. Employment among users of a medically supervised safer injection facility. Richardson L; Wood E; Zhang R; Montaner J; Tyndall M; Kerr T Am J Drug Alcohol Abuse; 2008; 34(5):519-25. PubMed ID: 18821450 [TBL] [Abstract][Full Text] [Related]
15. Factors associated with public injecting among users of Vancouver's supervised injection facility. McKnight I; Maas B; Wood E; Tyndall MW; Small W; Lai C; Montaner JS; Kerr T Am J Drug Alcohol Abuse; 2007; 33(2):319-25. PubMed ID: 17497555 [TBL] [Abstract][Full Text] [Related]
16. IDU perspectives on the design and operation of North America's first medically supervised injection facility. Small W; Ainsworth L; Wood E; Kerr T Subst Use Misuse; 2011; 46(5):561-8. PubMed ID: 20874006 [TBL] [Abstract][Full Text] [Related]
17. Accessing care for injection-related infections through a medically supervised injecting facility: a qualitative study. Small W; Wood E; Lloyd-Smith E; Tyndall M; Kerr T Drug Alcohol Depend; 2008 Nov; 98(1-2):159-62. PubMed ID: 18650034 [TBL] [Abstract][Full Text] [Related]
18. Prevalence and correlates of hepatitis C infection among users of North America's first medically supervised safer injection facility. Wood E; Kerr T; Stoltz J; Qui Z; Zhang R; Montaner JS; Tyndall MW Public Health; 2005 Dec; 119(12):1111-5. PubMed ID: 16214189 [TBL] [Abstract][Full Text] [Related]
19. Potential uptake and correlates of willingness to use a supervised smoking facility for noninjection illicit drug use. Collins CL; Kerr T; Kuyper LM; Li K; Tyndall MW; Marsh DC; Montaner JS; Wood E J Urban Health; 2005 Jun; 82(2):276-84. PubMed ID: 15872188 [TBL] [Abstract][Full Text] [Related]
20. Non-fatal overdose among a cohort of active injection drug users recruited from a supervised injection facility. Milloy MJ; Kerr T; Mathias R; Zhang R; Montaner JS; Tyndall M; Wood E Am J Drug Alcohol Abuse; 2008; 34(4):499-509. PubMed ID: 18584579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]